Pacific Biosciences of California, Inc.
PACB
$1.33
$0.064.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1,802.70% | 37.42% | 75.81% | -445.01% | 102.89% |
| Total Depreciation and Amortization | -57.54% | -72.66% | -67.93% | 3,002.87% | -6.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.50% | -28.89% | -89.34% | -26.55% | -355.31% |
| Change in Net Operating Assets | -10.45% | 118.57% | 38.84% | 90.58% | 208.10% |
| Cash from Operations | 37.78% | 58.85% | 45.86% | 41.79% | 46.75% |
| Capital Expenditure | 46.75% | -89.07% | 62.81% | 64.19% | 20.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.07% | -15.54% | -67.01% | 254.09% | 192.73% |
| Cash from Investing | -55.31% | -18.05% | -67.10% | 232.51% | 187.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -11,180.90% |
| Issuance of Common Stock | -- | 80.91% | -- | -71.57% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 80.91% | 100.00% | -70.11% | 38.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.78% | 107.71% | -118.26% | 103.04% | 89.01% |